Syndax Pharmaceuticals is up a bit on the day, funds flowing in kept the price up 1.14% since yesterday.
Currently SNDX isn't at a clear support/resistance line that seems tradable. Syndax Pharmaceuticals hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. SNDX might find some support at the 21.58 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on Syndax Pharmaceuticals right now, so not much useful information here. The current Analysts Sentiment Score is 9.06. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2024-03-27 HC Wainwright reiterated their rating of Buy and added a price target of $41.00. JPMorgan Chase & Co. provided a price target boost of 9.68% to $34.00 from $31.00 on 2024-03-20. On 2024-01-31 there was a downgrade announced by Scotiabank from Sector Outperform to Sector Perform and dropped their 1 year price target to $23.00 which is down from $36.00. Mizuho initiated a rating of Buy on 2023-12-22 and added a price target of $45.00. On 2023-10-26 Stifel Nicolaus lowered their price target by -5.26% to $36.00. Bank of America announced that they are initiating coverage with a rating of Buy on 2023-10-25 and added a price target of $29.00. The Goldman Sachs Group initiated a rating of Buy on 2023-10-11 and provided a price target of $30.00. Robert W. Baird provided a price target decease of -12.5% to $28.00 from $32.00 on 2023-10-03. Guggenheim boosted their price targ by 2.38% to $43.00 on 2023-10-03. On 2023-07-26 Barclays increased their price target by 9.68% to $34.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
SNDX | 9.06 | 11.72 | -3.77 | 13.25 | -3.09 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
SNDX | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
SNDX | 10.02 | %12.2337 | 5.7 | 15.906 | 8500000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 95 | 0.79 | -3.72 | -2.26 | -0.85 | 7.67 | 40.04 | 55.08 | 6.66 | 6.30 | 3.43 | -14013.76 | -12974.30 | 16.84 | 4.74 | 9.36 | 8.41 |
Healthcare | 230 | 0.88 | -1.52 | -0.30 | -2.16 | 5.72 | 27.64 | 53.66 | 8.86 | 8.57 | 8.32 | -12704.99 | -11984.82 | 18.91 | 4.24 | 6.74 | 5.55 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
SNDX |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KURA | Kura Oncology, Inc. | 0.74 | -0.31 | -3.52 | -10.52 | -21.00 | -25.76 | 70.34 | 59 | -12.34 | -8.94 | -6.18 | -4497.47 | -12834.13 | 0 | 0 | 7.89025 |
PENN | PENN Entertainment, Inc. | 0.71 | -1.48 | -4.39 | 4.33 | 7.06 | 29.66 | -21.06 | 74 | -0.29 | -1.56 | -3.64 | -8608.46 | -7842.12 | 0 | 0 | 9.2474 |
YMAB | Y-mAbs Therapeutics, Inc. | 0.66 | -2.95 | -9.06 | -28.01 | -31.51 | -15.00 | 100.38 | 24 | 9.59 | 32.38 | 48.32 | -2113.67 | -19525.09 | 0 | 0 | 10.5121 |
AGIO | Agios Pharmaceuticals, In | 0.64 | 0.39 | -1.41 | 21.16 | 20.41 | 67.08 | 149.75 | 88 | 26.04 | 40.64 | 75.74 | 0.00 | -38650.68 | 0 | 0 | 10.8809 |
PCVX | Vaxcyte, Inc. Common Stoc | 0.62 | -1.29 | -7.25 | -23.47 | 9.60 | 24.09 | 69.35 | 31 | 30.28 | 74.26 | 86.97 | -3456.90 | -27868.65 | 0 | 0 | 9.59374 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.